New Research Analysis Shows VINIA Reduces Oxidation Of LDL-Cholesterol To Support Cardiovascular Improved Functioning
Retrieved on:
Monday, November 15, 2021
People, Degenerative disease, Meta-analysis, News, Plasma, BHSC, LDL, NMCD, Inflammation, Clinical study design, List of MDPI academic journals, Red blood cell, Antioxidant, INT, Company, Awareness, Metabolism, Glucose, Nutrition, Male, Complement, Risk, Canadian Securities Exchange, User experience, Guler, Bookkeeping, Dietary supplement, Viticulture
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") reports that recent research analysis provides additional support for anti-oxidation structure/function claims of VINIA®. This analysis, when added to the clinical study [1] conducted by the Company, provides a clear substantiation to BioHarvest's claims relating to anti-oxidation, lipid anti-oxidation, and scavenging free radicals.
Key Points:
- Projected sales of Cannabis will require the Company to obtain production and/or export licensing which cannot be assured.
- All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control.
- BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
- Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.